Upgrade to SI Premium - Free Trial

SURNF (SURNF)

0.13 +0.01 (8.33%)

Chart
Today 6M 1Y 5Y

Latest Headlines

NetworkNews Audio Announces Audio Press Release (APR) Discussing Overcoming Limitations on First-Generation GLP-1 Drug Therapies May 15, 2026 8:30 AM - Globe NewsWire SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Developing Distinct Next-Gen GLP-1 Built Around Novel Peptide May 14, 2026 8:30 AM - Globe NewsWire SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advancing a Differentiated Next-Gen GLP-1 Platform May 12, 2026 8:30 AM - Globe NewsWire The Next Generation of the GLP-1 Revolution Is Already Underway May 11, 2026 8:30 AM - Globe NewsWire SureNano Science starts FDA toxicology studies for diabetes drug GEP-44 April 24, 2026 8:09 AM - StreetInsider SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio April 24, 2026 8:09 AM - StreetInsider Full Article List